Menu Search
Equities

Amgen Inc

AMGX:GER

Amgen Inc

Actions
  • Price (EUR)281.90
  • Today's Change6.80 / 2.47%
  • Shares traded719.00
  • 1 Year change+16.39%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Amgen Inc had little change in net income (from 6.55bn to 6.72bn) despite revenues that grew 7.09% from 26.32bn to 28.19bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 24.34% to 29.85%.
Gross margin60.48%
Net profit margin13.00%
Operating margin19.91%
Return on assets4.66%
Return on equity55.72%
Return on investment5.87%
More ▼

Cash flow in USDView more

In 2023, Amgen Inc increased its cash reserves by 43.45%, or 3.32bn. Cash Flow from Financing totalled 21.05bn or 74.66% of revenues. In addition the company generated 8.47bn in cash from operations while cash used for investing totalled 26.20bn.
Cash flow per share18.18
Price/Cash flow per share16.15
Book value per share14.00
Tangible book value per share-74.51
More ▼

Balance sheet in USDView more

Amgen Inc has a Debt to Total Capital ratio of 88.92%, a lower figure than the previous year's 771.16%.
Current ratio1.32
Quick ratio0.9553
Total debt/total equity8.02
Total debt/total capital0.8892
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)2.85%
Div growth rate (5 year)10.04%
Payout ratio (TTM)141.80%
EPS growth(5 years)-0.2187
EPS (TTM) vs
TTM 1 year ago		-44.45
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.